Lurbinectedin-Induced Tumor Lysis Syndrome in Small Cell Neuroendocrine Cancer of the Cecum: A First-Ever Case Report

Ahsan Wahab; Abdul Rafae; Kamran Mushtaq; Krishna Venkata; Rehan Sarmad

doi:10.12659/AJCR.932081

14 June 2021 : Case report USA

Lurbinectedin-Induced Tumor Lysis Syndrome in Small Cell Neuroendocrine Cancer of the Cecum: A First-Ever Case Report

Unusual clinical course, Unusual or unexpected effect of treatment, Adverse events of drug therapy

Ahsan Wahab^1AEF*, Abdul Rafae

^2BD, Kamran Mushtaq^3BD, Krishna Venkata^4EF, Rehan Sarmad^5AEF

DOI: 10.12659/AJCR.932081

Am J Case Rep 2021; 22:e932081

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 1. Histopathology of liver biopsy specimen showing (A) hematoxylin and eosin staining and immunohistochemical staining positive for (B) synaptophysin, (C) chromogranin, and (D) Ki-67.

Back to the Article

Lurbinectedin-Induced Tumor Lysis Syndrome in Small Cell Neuroendocrine Cancer of the Cecum: A First-Ever Case Report

Your Privacy